SINERGIUM BIOTECH is promoting the construction of a new plant for the formulation, filling and conditioning of sterile liquids into pre-filled injectable forms. The final product includes flu vaccines and biotech products (recombinant proteins, mAbs, etc.). The building also has a 2,000 m² office area.
AXIOM’s team has drafted the detailed design and carried out the Project Management, Site Management and Supervision and Health and Safety Management, both in the civil works and in the installations.
